Found 9 matching trials
Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration
PHASE1The purpose of this study is to evaluate the safety and the efficacy of Gly...
Location
Medicines Evaluation Unit
Efficacy and Safety of Glycopyrrolate Bromide of COPD Patients
PHASE2The purpose of this study is to evaluate the efficacy and safety of CHF 525...
Location
Chiesi Clinical Trial Site 1017
A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease
PHASE2The purpose of this study is to evaluate the dose-response of different dos...
Location
Chiesi Investigational Site
Biopharmaceutical Study of Glyco pMDI With or Without Charcoal Block vs IV Bolus in Healthy Volunteers
PHASE1The purpose of this study is to investigate the pharmacokinetics, the absol...
Location
Medicines Evaluation Unit
Triple in Asthma Dose Finding
PHASE2Primary objective
The primary objective was to evaluate the efficacy of a ...
Location
Chiesi Clinical Trial Site 0105
A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)
PHASE1The purpose of this study is to evaluate the potential for cardiac repolari...
Location
PAREXEL Baltimore Early Phase Clinical Unit
Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD
PHASE2The study was designed to investigate the efficacy and safety of different ...
Location
Clinical Trial Site 203-002
Efficacy of LAMA Added to ICS in Treatment of Asthma (ELITRA)
PHASE2Primary objective
The primary objective was to evaluate the superiority of...
Location
Chiesi Clinical Trial Site 0107
Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001
PHASE1To evaluate systemic pharmacokinetics of CHF6001 following concomitant admi...